Cargando…
Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines
Current therapies are insufficient for metastatic prostate cancer (PCa) in men and dogs. As human castrate-resistant PCa shares several characteristics with the canine disease, comparative evaluation of novel therapeutic agents is of considerable value for both species. Novel isoquinolinamine FX-9 e...
Autores principales: | Schille, Jan Torben, Nolte, Ingo, Packeiser, Eva-Maria, Wiesner, Laura, Hein, Jens Ingo, Weiner, Franziska, Wu, Xiao-Feng, Beller, Matthias, Junghanss, Christian, Murua Escobar, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888667/ https://www.ncbi.nlm.nih.gov/pubmed/31703454 http://dx.doi.org/10.3390/ijms20225567 |
Ejemplares similares
-
Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines
por: Weiner, Franziska, et al.
Publicado: (2021) -
Novel Isoquinolinamine and Isoindoloquinazolinone Compounds Exhibit Antiproliferative Activity in Acute Lymphoblastic Leukemia Cells
por: Roolf, Catrin, et al.
Publicado: (2019) -
Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis
por: Packeiser, Eva-Maria, et al.
Publicado: (2020) -
Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
por: Weiner, F., et al.
Publicado: (2021) -
PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death
por: Schille, Jan Torben, et al.
Publicado: (2021)